The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Long or Highly Irregular Menstrual Cycles as a Marker for Risk of Type 2 Diabetes Mellitus
Abstract
CONTEXT: Although oligomenorrhea has been associated cross-sectionally with insulin resistance and glucose intolerance, it is not known whether oligomenorrhea is a marker for increased future risk of type 2 diabetes mellitus (DM). OBJECTIVE: To prospectively assess risk of type 2 DM in women with a history of long or highly irregular menstrual cycles. DESIGN AND SETTING: The Nurses' Health Study II, a prospective observational cohort study. PARTICIPANTS: A total of 101 073 women who had no prior history of DM and who reported their usual menstrual cycle pattern at age 18 to 22 years on the baseline (1989) questionnaire. MAIN OUTCOME MEASURE: Incident reports of DM, with follow-up through 1997, compared among women categorized by menstrual cycle length (5 categories). RESULTS: During 564 333 person-years of follow-up, there were 507 cases of type 2 DM. Compared with women with a usual cycle length of 26 to 31 days (referent category) at age 18 to 22 years, the relative risk (RR) of type 2 DM among women with a menstrual cycle length that was 40 days or more or was too irregular to estimate was 2.08 (95% confidence interval [CI], 1.62-2.66), adjusting for body mass index at age 18 years and several other potential confounding variables. The RR of type 2 DM associated with long or highly irregular menstrual cycles was greater in obese women, but was also increased in nonobese women (at body mass indexes at age 18 years of <25, 25-29, and >/=30 kg/m, RRs were 1.67 [95% CI, 1.14-2.45], 1.74 [95% CI, 1.07-2.82], and 3.86 [95% CI, 2.33-6.38], respectively). CONCLUSION: Women with long or highly irregular menstrual cycles have a significantly increased risk for developing type 2 DM that is not completely explained by obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For this reason, PCOS is associated with a two times increased risk for type 2 diabetes (T2D) [15].”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [15]
Citations
Cites
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.
Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010492 · Cited by 2,901
Self-citationHarris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Diamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6148 · Cited by 1,107
Screening for type 2 diabetes.
Engelgau, M. M., Narayan, K. M. V., & Herman, W. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1563 · Cited by 1,026
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
Adams, J., POLSON, D. W., & Franks, S. (1986) · BMJ · doi:10.1136/bmj.293.6543.355 · Cited by 975
Cited by
Sorted by citations
Items 201–300 of 361
Rubba, F., Mattiello, A., Chiodini, P., Celentano, E., Galasso, R., Ciardullo, A. V., Gentile, M., Triassi, M., Rubba, P., & Panico, S. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.12.004 · Cited by 14
“Overweight and smoking seem to be associated with a general variability and irregularity of cycle length pattern, whereas there are no definite data about nutritional influences and lipid correlates [1,2].”
BackgroundInfluentialComparison of metformin and thiazolidinediones in the management of polycystic ovary syndrome
Baillargeon, J., Iuorno, M. J., & Nestler, J. E. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200208000-00003 · Cited by 14
Proactive Management of Menstrual Cycle Abnormalities in Young Women
Barron, M. L. (2004) · The Journal of Perinatal & Neonatal Nursing · doi:10.1097/00005237-200404000-00003 · Cited by 14
Khoudary, S. R. E., Qi, M., Chen, X., Matthews, K. A., Allshouse, A. A., Crawford, S. L., Derby, C. A., Thurston, R. C., Kazlauskaite, R., Barinas‐Mitchell, E., et al. (2021) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001876 · Cited by 13
“Several studies assessed the link between menstrual cycle irregularities and cardiometabolic disease risk.(5,10,20,21) How-”
InfluentialMenstrual cycle length and adverse pregnancy outcomes among women in Project Viva
Soria‐Contreras, D. C., Perng, W., Rifas‐Shiman, S. L., Hivert, M., Chavarro, J. E., & Oken, E. (2022) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12866 · Cited by 13
Tan, S., Vollmar, N., Benson, S., Sowa, J., Bechmann, L. P., Gerken, G., Führer, D., & Canbay, A. E. (2015) · International Journal of Endocrinology · doi:10.1155/2015/254169 · Cited by 12
“burden of IR seen inwomenwith PCOS, affectedwomenmay have an increased risk of type 2 diabetes mellitus, cardiovascular disease [4, 5], and also nonalcoholic fatty liver disease (NAFLD) [6–11].”
BackgroundKoo, M., Chen, C.-H., Tsai, K.-W., Lu, M., & Lin, S. (2015) · BMC Women s Health · doi:10.1186/s12905-015-0220-3 · Cited by 13
“Furthermore, menstrual cycle irregularity before middle age had been shown to increase the risk of cardiovascular disease [5], type 2 diabetes [6], and osteoporosis [7].”
BackgroundLevine, L. D., Kim, K., Purdue‐Smithe, A., Sundaram, R., Schisterman, E. F., Connell, M. T., DeVilbiss, E. A., Alkhalaf, Z., Radoc, J. G., Louis, G. M. B., et al. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz003 · Cited by 13
“Menstrual irregularity has previously been associated with a variety of negative health outcomes, including increased risk for type 2 diabetes mellitus [34] and coronary heart disease [35].”
BackgroundReview: PCOS, insulin resistance and long-term risks for diabetes and vascular disease
Sattar, N. A. (2009) · The British Journal of Diabetes · doi:10.1177/1474651408101369 · Cited by 13
Shapley, M., Jordan, K. P., & Croft, P. R. (2007) · Family Practice · doi:10.1093/fampra/cmm068 · Cited by 12
“Prolonged period 106 (14) 38 (28) Intermenstrual bleeding or postcoital bleeding 139 ( 19 ) 49 (36) Short cycle, intermenstrual bleeding or postcoital bleeding 301 (41) 93 (67) Short cycle, intermenstrual bleeding, postcoital bleeding or prolonged period 340 (46) 101 (73)”
BackgroundInsulin sensitivity and premenstrual syndrome
Trout, K. K., & Teff, K. L. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0079-4 · Cited by 14
“It is of interest to note that women with diabetes have a higher prevalence of menstrual cycle disorders in general [13, 14 ].”
BackgroundKim, C., Aroda, V. R., Goldberg, R. B., Younes, N., Edelstein, S. L., Carrion-Petersen, M. L., Ehrmann, D. A., & Diabetes Prevention Program Outcomes Study Group (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01829 · Cited by 12
The American Diabetes Association's 57th Annual Advanced Postgraduate Course
Bloomgarden, Z. T. (2010) · Diabetes Care · doi:10.2337/dc11-zb01 · Cited by 12
Prediction and prevention of type 2 diabetes
Makrilakis, K., & Katsilambros, N. L. (2003) · HORMONES · doi:10.14310/horm.2002.1179 · Cited by 11
Contemporary and Traditional Perspectives of Polycystic Ovarian Syndrome (PCOS): A Critical Review
Kadam, R., Shinde, K., Kadam, D. R., Kulkarni, D. M., & Dimple (2014) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-13968998 · Cited by 11
Dietary intake and menstrual cycle changes in international level young athletes
Miyamoto, M., Hanatani, Y., & Shibuya, K. (2021) · The Journal of Sports Medicine and Physical Fitness · doi:10.23736/s0022-4707.20.11392-6 · Cited by 11
Association Between Menstrual Irregularity and Dry Eye Disease
Song, J., Kim, M., Paik, J., Kim, H. S., & Na, K. (2015) · Cornea · doi:10.1097/ico.0000000000000727 · Cited by 11
Metabolic Consequences of Obesity
Hu, F. B. (2008) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195312911.003.0008 · Cited by 11
Klusmann, H., Kapp, C., Engel, S., Schumacher, T., Bücklein, E., Knaevelsrud, C., & Schumacher, S. (2024) · Psychopathology · doi:10.1159/000535565 · Cited by 10
“Above interindividual differences in average length, intraindividual regularity of length has been associated with a higher risk for some somatic and mental illnesses [6 – 9].”
Environmental Exposures and Polycystic Ovary Syndrome: A Review
Peebles, E., & Mahalingaiah, S. (2024) · Seminars in Reproductive Medicine · doi:10.1055/s-0044-1801405 · Cited by 11
[Retracted] Sleep Status and Menstrual Problems among Chinese Young Females
He, H. J., Yu, X., Chen, T., YANG, F. B., Zhang, M., & Ge, H. (2021) · BioMed Research International · doi:10.1155/2021/1549712 · Cited by 10
RetractedGeschlechtsspezifische Aspekte bei der koronaren Herzkrankheit
Ladwig, K., & Waller, C. F. (2014) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-014-2020-6 · Cited by 11
Long-term health consequences of polycystic ovary syndrome
Κousta, E., & Franks, S. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545191.007 · Cited by 11
Sasaki, N., Akiyama, H., Kawakami, N., & Nishi, D. (2021) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2021.2010699 · Cited by 9
Farland, L. V., Liu, C.-L., Diop, H., Cabral, H., Missmer, S. A., Coddington, C. C., Hwang, S. S., & Stern, J. E. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.11.012 · Cited by 9
Sasaki, N., Imamura, K., Watanabe, K., Hidaka, Y., Ando, E., Eguchi, H., Inoue, A., Tsuno, K., Komase, Y., Iida, M., et al. (2022) · Systematic Reviews · doi:10.1186/s13643-022-02066-4 · Cited by 12
“Menstrual cycle disorders, including shorter or longer cycles in reproductive age, are related to infertility [3–5], breast and ovarian cancer [6, 7], diabetes [8], and cardiovascular disease [9, 10].”
BackgroundLegro, R. S. (2004) · Elsevier eBooks · doi:10.1016/b978-012444562-8/50030-6 · Cited by 9
The clinical characteristics of Korean women with polycystic ovary syndrome
Park, H. R., Oh, J. Y., Hong, Y. S., Sung, Y., Lee, H.-J., & Cheong, H. W. (2007) · The Korean Journal of Internal Medicine · Cited by 8
Lu, M., Hsieh, M.-C., Koo, M., & Lai, N. (2015) · Rheumatology International · doi:10.1007/s00296-015-3324-z · Cited by 8
Does Ramadan fasting has any effects on menstrual cycles?
Yavangi, M., Amirzargar, M. A., Amirzargar, N., & Dadashpour, M. (2013) · Europe PMC (PubMed Central) · Cited by 8
Socioemotional Correlates of Self-Reported Menstrual Cycle Irregularity in Premenopausal Women
Newton, T. L., & Philhower, C. L. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000097346.39776.59 · Cited by 8
Morrison, J. A., Glueck, C. J., Daniels, S. R., Horn, P. S., & Wang, P. (2012) · Metabolism · doi:10.1016/j.metabol.2012.02.014 · Cited by 8
“Our findings of a pro-atherogenic association of low SHBG and menstrual delay in adolescence with increasing ApoB/ApoA1 foretell outcomes in adult women, where women with a history of irregular cycles have increased risk of coronary heart disease (CHD) and type 2 diabetes mellitus compared to women with regular cycles…”
BackgroundInteractions of insulin and estrogen in the regulation of cell proliferation and carcinogenesis
Suba, Z., & Kásler, M. (2012) · Orvosi Hetilap · doi:10.1556/oh.2012.29287 · Cited by 8
Gut Hormones, Obesity, Polycystic Ovarian Syndrome, Malignancy, and Lipodystrophy Syndromes
Bloomgarden, Z. T. (2007) · Diabetes Care · doi:10.2337/dc07-zb07 · Cited by 8
“5% had type 2 diabetes (37), and in the Nurses’ Health Study, the rate of conversion to type 2 diabetes doubled in oligomenorrheic women, independent of weight (38).”
BackgroundAppiah, D., Hedderson, M. M., Kim, C., Sidney, S. S., Sternfeld, B., Quesenberry, C. P., Wellons, M., & Gunderson, E. P. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110593 · Cited by 7
Nightshift work and irregular menstrual cycle: 8-year follow-up cohort study
Kim, K., Lee, M. Y., Chang, Y., & Ryu, S. (2024) · Occupational Medicine · doi:10.1093/occmed/kqad162 · Cited by 7
Polycystic Ovarian Syndrome, Biomarkers, and Metformin: Research, Risk, and Reality
Sattar, N. A., & Nelson, S. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2486 · Cited by 7
“66), adjusting for BMI at age 18 yr and several other potential confounding variables (17).”
BackgroundShifts in Color Discrimination during Early Pregnancy
Orbán, L. L., & Dastur, F. N. (2012) · Evolutionary Psychology · doi:10.1177/147470491201000206 · Cited by 7
Dmitrović, R., & Legro, R. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-400-1_11 · Cited by 7
Kwan, B. S., Kim, S. C., Jo, H. C., Baek, J., & Park, J. E. (2022) · Healthcare · doi:10.3390/healthcare10040649 · Cited by 8
“In previous reports [12,13,15,16,22,23], the association between menstrual irregularities and diabetes appeared inconsistent depending on the age and menopausal status of the sample group.”
BackgroundResultDiabetes Issues in Women and Children
Bloomgarden, Z. T. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2457 · Cited by 6
Jung, H.-N., Suh, D., Jeong, W. C., Ryu, J., Kim, Y., Yoon, S., & Kim, H. (2023) · Annals of Occupational and Environmental Medicine · doi:10.35371/aoem.2023.35.e30 · Cited by 6
“17 Furthermore, menstrual cycle changes increase the risk of severe health problems, such as breast cancer, 18 type 2 diabetes, 19 cardiovascular disease, 20 and premature mortality.”
BackgroundContributions of white adipose tissue to energy requirements for female reproduction
Anaya, E. S., de Groot, E. L., Lydon, J. P., Pangas, S. A., & Hartig, S. M. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.04.012 · Cited by 7
Classification and identification of risk factors for type 2 diabetes
Tang, S., Zhao, X., An, X., Sun, W., Kang, X., Sun, Y., Jiang, L., Gao, Q., Li, Z., Ji, H., et al. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v16.i2.100371 · Cited by 8
Ganie, M. A., Rashid, A., Baba, M. S., Zargar, M. A., Wani, I. A., Nisar, S., Wani, I. A., Douhath, S., Sriwastawa, M., Geer, M. I., et al. (2023) · Clinical Endocrinology · doi:10.1111/cen.14964 · Cited by 6
“20,21 However, emerging evidence suggests that even among women with PCOS, the subset with polymenorrhoea exhibits milder glucose impairment and lower levels of insulin resistance compared to those with oligome-norrhoea.”
BackgroundHerzinsuffizienz – geschlechtsspezifische Aspekte?
Regitz‐Zagrosek, V., Lehmkuhl, E., & Lehmkuhl, H. B. (2008) · Der Internist · doi:10.1007/s00108-008-2053-8 · Cited by 6
Polycystic ovary syndrome (PCOS) and gestational diabetes mellitus (GDM) risk
Issat, T., Nowicka, M., & Jakimiuk, A. J. (2015) · Ginekologia Polska · doi:10.17772/gp/2429 · Cited by 6
Palma, J. C., Byhen, E. L., Ibáñez, L., Macedo, L. B., Palma, C. P., & Velázquez, C. R. (2017) · Revista Médica Del Hospital General De México · doi:10.1016/j.hgmx.2017.03.001 · Cited by 6
“However, they have no effect on beta cell activity and therefore on progression to DM2 or gestational diabetes.(18,19) Incretins and DPP-4 inhibitors have been shown to enhance pancreatic -cell activity, inhibit apoptosis, and promote weight loss because of their anorectic effect, thus providing adequate weight contro…”
BackgroundKuba, V. M., Cavalieri, P. M., Christóforo, Â. C., Faria, R., Caetano, R., Coeli, C. M., & Athayde, A. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000600008 · Cited by 6
Birth weight and childhood growth in daughters of women with irregular menstrual cycles
Wang, E. T., Cirillo, P. M., Kao, C., Cohn, B. A., & Cedars, M. I. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.788638 · Cited by 6
“Large well-established, observational studies have shown an association between irregular menstrual cycles (MCs) and outcomes of type 2 diabetes mellitus [1] and coronary heart disease [2,3], citing polycystic ovary syndrome (PCOS) as the most likely pathway.”
BackgroundDiamanti‐Kandarakis, E., Baillargeon, J., & Jurno, M. J. (2003) · Cited by 6
Die Insulinresistenz beim polyzystischen Ovar-Syndrom
Schröder, A. K., Tauchert, S., Ortmann, O., Diedrich, K., & Weiss, J. M. (2003) · Wiener klinische Wochenschrift · doi:10.1007/bf03041041 · Cited by 6
Buchanan-Smith, L. I. M., Pang, A. H., Yeshitila, N., Parsons, E. N., & Blodgett, J. M. (2025) · Journal of Women s Health · doi:10.1177/15409996251365804 · Cited by 5
Chu, A. H. Y., Aris, I. M., Ng, S., Loy, S. L., Bernard, J. Y., Tint, M. T., Yuan, W. L., Godfrey, K. M., Chan, J. K. Y., Shek, L. P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66147-x · Cited by 5
Tracking Health and Fitness Variables in Females: Menstrual Cycle Considerations
Bruinvels, G., & Pedlar, C. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-21881-1_13 · Cited by 5
Conservative Management of Gynecologic Diseases
Diamanti‐Kandarakis, E., & KANDARAKIS, H. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.035 · Cited by 5
Song, I., Ki, E. Y., Han, K., Ryu, J., & Park, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040454 · Cited by 5
“Women with long (a usual cycle length of 40 days or more) or highly irregular menstrual cycles have a significantly increased risk for developing type 2 diabetes mellitus [4], and the prevalence of type 2 diabetes is higher among women with a history of menstrual irregularity [5].”
BackgroundRole of hormonal risk factors in oral cancer development
Suba, Z., Maksa, G., Mihályi, S., & Takács, D. (2009) · Orvosi Hetilap · doi:10.1556/oh.2009.28595 · Cited by 5
Adolescent Obesity: Identifying A New Group of At-Risk Youth
Trent, M. (2002) · Pediatric Annals · doi:10.3928/0090-4481-20020901-08 · Cited by 5
Angiotensin Receptor Blockers: Cardiovascular Protection in the Metabolic Syndrome
DEEDWANIA, P. C., & Schmieder, R. E. (2006) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2006.018 · Cited by 5
Should patients with polycystic ovarian syndrome be treated with metformin
Nestler, J. E. (2002) · Cited by 5
Krstevska, B., Mishevska, S. J., Nakova, V. V., & Serafimoski, V. (2021) · PRILOZI · doi:10.2478/prilozi-2021-0022 · Cited by 4
“The risk for dysglycemia is the highest among PCOS patients with both anovulation and hyperandrogenism, amplified by obesity, or the classic NIH phenotype [15].”
BackgroundAhmed, A., Khadija, S., & Irshad, A. (2022) · Pakistan BioMedical Journal · doi:10.54393/pbmj.v5i3.138 · Cited by 4
Heller, C., Güllmar, D., Koeppel, C. J., Rojczyk, P., Stein, H., Taylor, C. M., Jacobs, E. G., Derntl, B., Kikinis, Z., Walter, M., et al. (2024) · npj Women s Health · doi:10.1038/s44294-024-00023-1 · Cited by 6
Семенина, Г. Б. (2016) · Reproductive Endocrinology · doi:10.18370/2309-4117.2016.32.69-76 · Cited by 4
Risques à long terme du syndrome des ovaires polykystiques
Lefebvre, P., Raingeard, I., Renard, É., & Bringer, J. (2004) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2003.07.010 · Cited by 4
Noor, B., Rahman, J., & Hossain, K. (2009) · Journal of Scientific Research · doi:10.3329/jsr.v2i1.2573 · Cited by 4
Salcedo, A. C., Shehata, H., Berry, A., & Riba, C. (2022) · Journal of Metabolic Health · doi:10.4102/jir.v5i1.67 · Cited by 4
“16,24,26,42,43,44,45,46 The majority of participants did not have an elevated A1c or a history of hypertension or DM2, but this lack of association has been observed in prior studies on overall AUB as well.”
Syphilis susceptibility factors atlas: A wide-angled Mendelian randomization study
Xie, J., Guo, Y., Wang, M., Tong, M.-L., Zhu, X., & Lin, L. (2024) · Preventive Medicine · doi:10.1016/j.ypmed.2024.108033 · Cited by 3
Clinical profile of PCOS patients in a rural tertiary care hospital
Sharma, S. P., & Borade, J. S. (2019) · International Journal of Clinical Obstetrics and Gynaecology · doi:10.33545/gynae.2019.v3.i4a.281 · Cited by 3
“Nurses' Health study II reported that over an 8-year period, the conversion rate to type 2 diabetes among Oligomenorrhea women was approximately two-fold greater than that for eumenorrheic women, regardless of whether the Oligomenorrhea women were obese or lean, indicating that Oligomenorrhea was an independent predic…”
BackgroundSelf-reported history of comorbidities and markers of ovarian reserve among subfertile women
Mínguez‐Alarcón, L., Hammer, K. C., Williams, P. L., Souter, I. C., Ford, J. B., Rexrode, K. M., Hauser, R. B., Chavarro, J. E., & for the Earth Study Team (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02643-5 · Cited by 3
Gradient of clothing pressure for comfortable support wear
Mitsuno, T. T. (2023) · Journal of Textile Engineering & Fashion Technology · doi:10.15406/jteft.2023.09.00339 · Cited by 3
Pathogenesis and Management of Adiposity and Insulin Resistance in Polycystic Ovary Syndrome (PCOS)
Barber, T. M., Joharatnam, J., & Franks, S. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-68192-4_36 · Cited by 3
Popovska-Dimova, Z., & Krstevska, B. (2006) · PubMed · Cited by 3
The link between polycystic ovary syndrome and Type 2 diabetes: what do we know today?
Sathyapalan, T., & Atkin, S. L. (2011) · Diabetes Management · doi:10.2217/dmt.11.59 · Cited by 3
Mating Effort Predicts Human Menstrual Cycle Frequency
Gassen, J., Bradshaw, H. K., & Hill, S. E. (2018) · Evolutionary Psychology · doi:10.1177/1474704918812124 · Cited by 2
“Prior research investigating the factors that influence human menstrual cycle characteristics has found that longer, more irregular cycles are often associated with predictors of poor health: rapid weight change, stress, and disorders such as diabetes (Kato et al., 1999; Matteo, 1987; Solomon et al., 2001).”
BackgroundInfluentialGlyco-scope into the Role of Protein Glycosylation in the Female Reproductive Tract
Shathili, A. M. M., Handler, D. C. L., & Packer, N. H. (2020) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.1820.1e · Cited by 2
Unraveling the Link: A Comprehensive Literature Review of Type 2 Diabetes and Menopause Onset
Mohile, A., Hedaoo, R. P., Jadhav, S. J., Ainapure, A. S., Patil, M. V., & Khatwani, N. R. (2023) · Cureus · doi:10.7759/cureus.50743 · Cited by 2
“However, the highest relative risk of T2DM was associated with women who reported long menstrual cycles of 40 or more [26].”
BackgroundThe Patient at Risk for Diabetes Considering Prevention
Capes, S. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-008-9_19 · Cited by 2
“Furthermore, in the Nurses’ Health Study (a prospective study of 116,671 mostly Caucasian female nurses aged 24–43 at study inception in 1989), women with highly irregular or long (≥40 d) menstrual cycles had twice the risk of developing diabetes compared to women with regular, 26–31 d cycles (RR 2.1 [95% CI 1.6–2.7]…”
BackgroundInfluentialMenstrual cycle lengths—what can they tell us?
Nader, S. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.179 · Cited by 2
Rahmadianta, S. H. I., & Adiningsih, S. H. (2020) · Amerta Nutrition · doi:10.20473/amnt.v4i1.2020.23-29 · Cited by 2
Diagnosis and Treatment of Polycystic Ovary Syndrome in Adolescents
Волк, Ю. В., & Солнцева, А. В. (2021) · Репродуктивное здоровье Восточная Европа · doi:10.34883/pi.2021.11.1.014 · Cited by 2
Mengelkoch, S., Cunningham, K., Gassen, J., Targonskaya, A., Zhaunova, L., Salimgaraev, R., & Hill, S. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-60599-1 · Cited by 2
Thomas, A., Raba’ai, M. A. M., Rahmatullah, N. A., Talip, S. B., & Kendong, S. M. A. (2018) · Journal of Borneo-Kalimantan · doi:10.33736/jbk.615.2017 · Cited by 2
Baillargeon, J., & Farid, N. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_18 · Cited by 2
Alhammadi, M. H., Albogmi, A., Alzahrani, M. M., Shalabi, B., Fatta, F., & AlBasri, S. F. (2022) · Research Square · doi:10.21203/rs.3.rs-1330421/v1 · Cited by 2
Clinical and Hormonal Evaluation of Androgen Excess
Azziz, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_33 · Cited by 1
“These studies noted that the overall prevalence of menstrual dysfunction approximated 20% of the women studied, very similar to the rate of 22.9% reported by 101,073 women participating in the Nurses Health Study II ( 34 ).”
ResultInfluentialKelley, C. E., Brown, A. J., & Setji, T. L. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.941814 · Cited by 1
“In contrast, other studies have shown that irregular cycles are enough to predict risk for IGT/T2D, independent of the presence of hyperandrogenism [7,18].”
BackgroundResultAdolescent polycystic ovary syndrome: pathophysiology and implications of the disease
Gupta, S., Chen, D. K., Chandra, A., Metterle, L., Kesavan, S., & Agarwal, A. K. (2009) · Cited by 1
Jajoo, S., & Angik, R. (2013) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.5455/2320-1770.ijrcog20131208 · Cited by 1
Taponen, S. (2004) · Cited by 1
Genderaspekte bei koronarer Herzerkrankung
Seeland, U., Eifert, S., & Regitz‐Zagrosek, V. (2012) · Zeitschrift für Herz- Thorax- und Gefäßchirurgie · doi:10.1007/s00398-011-0908-0 · Cited by 1
Zaburzenia gospodarki węglowodanowej u kobiet z zespołem wielotorbielowatych jajników (PCOS)
Kuligowska-Jakubowska, M. (2012) · Cited by 1
Sonographic Features of the Liver Among Females With Type 2 Diabetes
Riestra‐Candelaria, B. L., Gonzalez-Rodriguez, L. A., Rodríguez-Mojica, W., Vázquez-Quiñones, L. E., & Jorge, J. C. (2019) · Journal of diagnostic medical sonography · doi:10.1177/8756479319834927 · Cited by 3
“In addition, an atypical menstrual cycle is also a risk factor of type 2 diabetes.(6) For these reasons, this study specifically evaluated liver health among nonsymptomatic women.”
A study on body mass index and menstrual cycle length in reproductive age women
Vashishta, S., & Gahlot, S. (2022) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20220121 · Cited by 1
Mishra, N., & Mishra, R. (2022) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2000 · Cited by 1
Puscheck, E. E. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.063 · Cited by 1
Dayanand, L., & Pj, R. (2023) · The Journal of Medical Research · doi:10.31254/jmr.2023.9404 · Cited by 1
Majeed, S., Moin, H., Shafi, R., Fatima, S., Zahra, T., & Zafar, S. (2024) · Women s Health · doi:10.1177/17455057241302559 · Cited by 1
Pan, A., Cromeens, M. G., Cedars, M. I., & Bleil, M. E. (2025) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002483 · Cited by 1
Metadata
- Authors
- Solomon, C. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Solomon, Caren G.
- ORCID
- Solomon, Caren G.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2001-11-21
- Volume
- 286
- Issue
- 19
- Pages
- 2421
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2043815784
- Cited by
- 362
- References
- 31
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 11 · 2023: 15 · 2022: 25 · 2021: 23 · 2020: 12 · 2019: 6 · 2018: 15 · 2017: 15 · 2016: 13 · 2015: 14 · 2014: 9 · 2013: 15 · 2012: 23
- FWCI
- 17.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA50385, R01CA050385)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- type 2 diabetes, menstrual cycle length, oligomenorrhea, menstrual irregularity, diabetes risk, obesity, insulin resistance, impaired glucose tolerance, women's health, Nurses' Health Study II
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Female, Humans, Menstrual Cycle, Obesity, Oligomenorrhea, Prospective Studies, Regression Analysis, Risk Factors, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review